Pacira Pharmaceuticals (NASDAQ: PCRX) reported Q1 EPS of ($0.19), $0.13 better than the analyst estimate of ($0.32). Revenue for the quarter came in at $36.7 million versus the consensus estimate of $35.4 million.

For earnings history and earnings-related data on Pacira Pharmaceuticals (PCRX) click here.